Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Eikon Therapeutics, Inc.

NASDAQ: EIKN · Life Sciences · 4 alerts · CIK 1861123

Share price
$5.39Close, Nov 16
Market cap
$292M
Shares outstanding
54.19MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Eikon Therapeutics, Inc. filings on SEC EDGAR ↗

6:46 AM ET 10-Q
Financial Results

Eikon Therapeutics Q3 2026 Results: Net Loss of $86.1M, Loss Widens

Eikon Therapeutics is a late clinical-stage biotechnology company that has not yet generated revenue from product sales and continues to incur substantial net losses. The filing highlights the development of its lead product candidates, including EIK1001 and EIK1003, and notes a restatement of financial statements for the nine months ended September 30, 2025, due to a material weakness in internal controls.

Key figure
Net loss $86.1M
6:35 AM ET 8-K
Financial Results

Eikon Therapeutics Financial Results

Eikon Therapeutics reported third quarter 2026 financial results, ending the period with $461.7 million in cash and extending its projected runway into Q1 2028. The company highlighted clinical progress in its oncology portfolio, including the dosing of the first patient in a registrational Phase 2/3 trial for EIK1001 and the submission of an IND for its prostate cancer candidate EIK1006.

Term
Q3 2026

“The third quarter was marked by important progress across Eikon’s oncology programs. At the 2026 ESMO Congress, we presented updated results from TeLuRide-005, providing additional evidence of durable anti-tumor activity for EIK1001 in combination with standard-of-care therapy in squamous NSCLC, building on earlier data in non-squamous NSCLC that we shared at ASCO.”

Roger M. Perlmutter, M.D., Ph.D., Chief Executive Officer and Board Chair

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.